MedTrace Logo

MSCopilot Users' Feedback in Real Life - Outcomes Regarding Integration in Patients' pathWay and Users' ExpeRience

NCT06922942 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-10-02

No results posted yet for this study

Summary

This US multicenter, prospective cohort study aims to evaluate how MSCopilot can be seamlessly integrated into the current care pathway and identify potential optimizations to enhance its impact on both MS patients and clinicians, facilitating broader implementation. Specifically, the study will assess:

* The overall integration of MSCopilot into routine clinical practice,
* Patients' ability to use MSCopilot at home without supervision,
* The need for patient support when using MSCopilot at home,
* User behavior based on usage analytics data from the MSCopilot mobile app and dashboard,
* Patient adherence to MSCopilot use in routine clinical practice,
* The adequacy of the onboarding/training process for HCPs,
* The effectiveness of HCPs onboarding/training in ensuring successful patient onboarding,
* The variances in user behavior and adherence to MSCopilot use according to socio-demographic factors and EDSS scores

Conditions

Interventions

DEVICE

MSCopilot Flower mobile application

MSCopilot Flower includes active tests for walking, cognition, dexterity and vision, and e-questionnaires related to fatigue and Anxiety

Sponsors & Collaborators

  • Ad scientiam

    lead OTHER

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-12
Primary Completion
2026-03-01
Completion
2026-03-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06922942 on ClinicalTrials.gov